In gut-associatedlymphoid tissue, altered SCRN1 expression may shift the balance between toleranceand immunogenicity to luminal antigens, thereby contributing to mucosalinflammation characteristic of IBD. This evidence concerns the gene SCRN1 and inflammatory bowel disease.